Trial record 1 of 2 for:
Vergent
Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. (VISUALIZE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06145048 |
|
Recruitment Status :
Recruiting
First Posted : November 22, 2023
Last Update Posted : January 24, 2024
|
Sponsor:
Vergent Bioscience, Inc.
Information provided by (Responsible Party):
Vergent Bioscience, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 2024 |
| Estimated Study Completion Date : | August 2024 |